Publications
Author/co-author of 230 publications; 84 full papers in peer reviewed international journals [IF of > 280.0 and h-index of 20.0].
DETERMINATION OF FREE AND GLUCURONATED HEXANE METABOLITES WITHOUT PRIOR HYDROLYSIS BY LIQUID- AND GAS-CHROMATOGRAPHY COUPLED WITH MASS SPECTROMETRY. P. MANINI, R. ANDREOLI, A. MUTTI, E. BERGAMASCHI, I. FRANCHINI. Toxicol Lett 108, 225-231, 1999. IF: 3.479
LUNG EPITHELIAL DAMAGE AT LOW CONCENTRATIONS OF AMBIENT OZONE.F BROECKAERT, K ARSALANE, C HERMANS, E BERGAMASCHI, A BRUSTOLIN, A MUTTI, A BERNARD. Lancet 353, 900-901, 1999. IF: 30.758
EXPOSURE TO HYDROCARBONS AND RENAL DISEASE: AN EXPERIMENTAL ANIMAL MODEL. A MUTTI, T COCCINI, R ALINOVI, G TOUBEAU, F BROEKAERT, E BERGAMASCHI, P MOZZONI, D NONCLERQ, A BERNARD, L MANZO. Renal Failure 21(3-4), 369-385, 1999. IF: 0.657
SOLID PHASE MICROEXTRACTION AND GAS CHROMATOGRAPHY-MASS SPECTROMETRY AS A TOOL FOR THE DETERMINATION OF MONOAROMATIC HYDROCARBONS IN BLOOD AND URINE: APPLICATION IN PEOPLE EXPOSED TO AIR POLLUTANTS. R. ANDREOLI, P. MANINI, E. BERGAMASCHI, A. BRUSTOLIN AND A. MUTTI.
Chromatographia, 50, 167-172, 1999. IF: 1.913
BIOMARKERS OF DOSE AND SUSCEPTIBILITY IN CYCLISTS EXPOSED TO MONOAROMATIC HYDROCARBONS. E. BERGAMASCHI, A. BRUSTOLIN, G. DE PALMA, P. MANINI, P. MOZZONI, R. ANDREOLI, S. CAVAZZINI, A. MUTTI.
Toxicol Lett, 108, 241-247, 1999. IF: 3.249
A SOLID-PHASE MICROEXTRACTION GAS CHROMATOGRAPHY-MASS SPECTROMETRY METHOD FOR THE DETERMINATION OF INHALATION ANAESTETICS IN URINE.
D. POLI, E. BERGAMASCHI, P. MANINI, R. ANDREOLI, A. MUTTI.
J Chromatogr B, 723/1, 115-125, 1999. IF: 1.913
ASSESSMENT OF NEUROBEHAVIORAL PERFORMANCE AS A FUNCTION OF CURRENT AND CUMULATIVE OCCUPATIONAL LEAD EXPOSURE. R. LUCCHINI, E. ALBINI, C. PERRONE, I. CORTESI, D. PLACIDI, E. BERGAMASCHI, F. TRAVERSA, L. ALESSIO.
Neurotoxicology, 21(5): 805-812, 2000. IF: 2.409
SERUM CLARA CELL PROTEIN: A SENSITIVE BIOMARKER OF INCREASED LUNG EPITHELIUM PERMEABILITY CAUSED BY AMBIENT OZONE. F. BROECKAERT, K. ARSALANE, C. HERMANS, E. BERGAMASCHI, A. BRUSTOLIN, A. MUTTI, A. BERNARD.
Environ Health Perspect, 108:533-537, 2000. IF: 6.191
LIQUID CHROMATOGRAPHY-ELECTROSPRAY TANDEM MASS SPECTROMETRY OF ACIDIC MONOAMINE METABOLITES. MANINI P, ANDREOLI R, CAVAZZINI S, BERGAMASCHI E, MUTTI A, NIESSEN WM.
J Chromatogr B - Biomed Sci Appl., 744(2):423-31, 2000. IF: 1.913
A NEW METHOD FOR THE ANALYSIS OF STYRENE MERCAPTURIC ACIDS BY LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY. MANINI P, ANDREOLI R, BERGAMASCHI E, DE PALMA G, MUTTI A, NIESSEN WM.
Rapid Commun Mass Spectrom.;14(21):2055-60, 2000. IF: 2.772
POLYMORPHISM OF QUINONE-METABOLIZING ENZYMES AND SUSCEPTIBILITY TO OZONE-INDUCED ACUTE EFFECTS. E. BERGAMASCHI, G. DE PALMA, P. MOZZONI, S. VANNI, M.V. VETTORI, F. BROECKAERT, A. BERNARD, A. MUTTI.
Am J Resp Crit Care Med, 163:1426-1431, 2001. IF: 10.609
POLYMORPHISM OF XENOBIOTIC-METABOLIZING ENZYMES AND EXCRETION OF STYRENE-SPECIFIC MERCAPTURIC ACIDS. DE PALMA G, MANINI P, MOZZONI P, ANDREOLI R, BERGAMASCHI E, CAVAZZINI S, FRANCHINI I, MUTTI A.
Chem Res Toxicol.; 14(10):1393-400, 2001. IF: 3.491
INTER- AND INTRA-INDIVIDUAL SOURCES OF VARIATION IN LEVELS OF URINARY STYRENE METABOLITES. SYMANSKI E, BERGAMASCHI E, MUTTI A.
Int Arch Occup Environ Health.; 74(5):336-44, 2001. IF: 1.938
ONE SHOT: A NOVEL METHOD TO DILATE THE NEPHROSTOMY ACCESS FOR PERCUTANEOUS LITHOTRIPSY. FRATTINI A, BARBIERI A, SALSI P, SEBASTIO N, FERRETTI S, BERGAMASCHI E, CORTELLINI P.
J Endourol.;15(9):919-23, 2001. IF: 1.035
GSTM1 POLYMORPHISM AND STYRENE METABOLISM: INSIGHTS FROM AN ACUTE ACCIDENTAL EXPOSURE. P. MANINI, G. DE PALMA, P. MOZZONI, R. ANDREOLI, D. POLI, E. BERGAMASCHI, I. FRANCHINI, A. MUTTI.
Toxicol Lett, 134: 201-208, 2002. IF: 3.479
BIOMARKERS OF OXIDATIVE STRESS AFTER CONTROLLED HUMAN EXPOSURE TO OZONE. M. CORRADI, R. ALINOVI, M. GOLDONI, M.V. VETTORI, G. FOLESANI, P. MOZZONI, S. CAVAZZINI, L. ROSSI, E. BERGAMASCHI, A. MUTTI.
Toxicol Lett,134: 219-225, 2002. IF: 3.249
INTEREST OF GENOTYPING AND PHENOTYPING OF DRUG-METABOLIZING ENZYMES FOR THE INTERPRETATION OF BIOLOGICAL MONITORING OF EXPOSURE TO STYRENE. V. HAUFROID, M. JAKUBOWSKI, B. JANASIK, D. LIGOCKA, J.P. BUCHET, E. BERGAMASCHI, P. MANINI et al.,
Pharmacogenetics, 12: 691-702, 2002. IF: 6.406
ACUTE RENAL AND HEPATIC FAILURE DUE TO ACCIDENTAL PERCUTANEOUS ABSORPTION OF 1,2-DICHLORPROPANE CONTAINED IN A COMMERCIAL PAINT FIXATIVE. FIACCADORI E, MAGGIORE U, ROTELLI C, GIACOSA R, ARDISSINO D, DE PALMA G, BERGAMASCHI E, MUTTI A.
Nephrol Dial Transplant.;18(1):219-20, 2003. IF: 3.568
BIOMARKERS OF RENAL EFFECTS IN CHILDREN AND ADULTS WITH LOW ENVIRONMENTAL EXPOSURE TO HEAVY METALS. DE BURBURE C, BUCHET JP, LEROYER A, NISSE C, HAGUENOER JM, BERGAMASCHI E, MUTTI A, BERNARD A. J Toxicol Environ Health 66: 1-16, 2003. IF: 1.676
GENETIC POLYMORPHISM OF DRUG-METABOLIZING ENZYMES AND STYRENE-INDUCED DNA DAMAGE. BUSCHINI AM, DE PALMA G, POLI P, MARTINO A, ROSSI C, MOZZONI P, SCOTTI E, BUZIO L, BERGAMASCHI E, MUTTI A.
Environ Mol Mutagenesis, 41: 241-252, 2003. IF: 2.101
ASSESSMENT OF BIOTRANSFORMATION OF THE ARENE MOIETY OF STYRENE IN VOLUNTEERS AND OCCUPATIONALLY EXPOSED WORKERS. MANINI P, BUZIO L, ANDREOLI R, GOLDONI M, BERGAMASCHI E, JAKUBOWSKI M, VODICKA P, HIRVONEN A, MUTTI A.
Toxicol Appl Pharmacol, 189: 160-169, 2003. IF: 3.364
DEVELOPMENT OF A SIMPLIFIED METHOD FOR THE SIMULTANEOUS DETERMINATION OF RETINOL, ALPHA-TOCHOPHEROL, AND BETA-CAROTENE IN SERUM BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY WITH ATMOSPHERIC PRESSURE CHEMICAL IONIZATION. ANDREOLI R, MANINI P, POLI D, BERGAMASCHI E, MUTTI A, NIESSEN W.
Anal Bioanal Chem, 378(4):987-994, 2004. IF 3.328
EFFECTS OF AMBIENT OZONE ON THE PROCOAGULANT STATUS AND SYSTEMIC INFLAMMATORY RESPONSE. HERMANS C, DENEYS V, BERGAMASCHI E, BERNARD A.
J Thromb Haemost., 3(9):2102-2103, 2005. IF 6.069
CYTOGENETIC BIOMARKERS, URINARY METABOLITES AND METABOLIC GENE POLYMORPHISMS IN WORKERS EXPOSED TO STYRENE. MIGLIORE L, NACCARATI A, COPPEDE F, BERGAMASCHI E, DE PALMA G, VOHO A, MANINI P, JARVENTAUS H, MUTTI A, NORPPA H, HIRVONEN A.
Pharmacogenet Genomics., 16(2):87-99, 2006. IF 4.409
RELATIONSHIP BETWEEN GENOTOXICITY BIOMARKERS IN SOMATIC AND GERM CELLS: FINDINGS FROM A BIOMONITORING STUDY. MIGLIORE L, COLOGNATO R, NACCARATI A, BERGAMASCHI E.
Mutagenesis, vol. 21(2):149-152, 2006. IF 3.160
NANOMATERIALS AND LUNG TOXICITY: INTERACTIONS WITH AIRWAYS CELLS AND RELEVANCE FOR OCCUPATIONAL HEALTH RISK ASSESSMENT. BERGAMASCHI E, BUSSOLATI O, MAGRINI A, BOTTINI M, MIGLIORE L, BELLUCCI S, IAVICOLI I, BERGAMASCHI A.
Int J Immunopathol Pharmacol. 19(4 SUPPL): 3-10, 2006. IF 2.793
SHIFT WORK AND AUTOIMMUNE THYROID DISORDERS. MAGRINI A, PIETROIUSTI A, COPPETA L, BABBUCCI A, BARNABA E, PAPADIA C, IANNACCONE U, BOSCOLO P, BERGAMASCHI E, BERGAMASCHI A.
Int J Immunopathol Pharmacol. 19 (4 SUPPL): 31-6, 2006. IF 2.793
QUANTUM DOT-DOPED SILICA NANOPARTICLES AS PROBES FOR TARGETING OF T-LYMPHOCYTES. BOTTINI M, D'ANNIBALE F, MAGRINI A, CERIGNOLI F, ARIMURA Y, DAWSON MI, BERGAMASCHI E, ROSATO N, BERGAMASCHI A, MUSTELIN T.
Int J Nanomedicine 2(2): 227-33, 2007. IF 2.612
METABOLIC SYNDROME AMONG OPERATORS USING VIDEO DISPLAY UNITS IN CALL CENTERS. PIETROIUSTI A, MAGRINI A, COPPETA L, BARONE S, SED B, MANULI G, BERGAMASCHI E, BERGAMASCHI A, PICCOLI B.
JWEH Suppl (3): 49–53, 2007
NON-FUNCTIONALIZED MULTI-WALLED CARBON NANOTUBES ALTER THE PARACELLULAR PERMEABILITY OF HUMAN AIRWAY EPITHELIAL CELLS. ROTOLI BM, BUSSOLATI O, BIANCHI MG, BARILLI A, BALASUBRAMANIAN C, BELLUCCI S, BERGAMASCHI E.
Toxicol Lett. 178(2):95-102, 2008. IF 3.479
CELL-TYPE SPECIFIC AND CYTOPLASMIC TARGETING OF PEGYLATED CARBON NANOTUBE-BASED NANOASSEMBLIES. CATO MH, D'ANNIBALE F, MILLS DM, CERIGNOLI F, DAWSON MI, BERGAMASCHI E, BOTTINI N, MAGRINI A, BERGAMASCHI A, ROSATO N, RICKERT RC, MUSTELIN T, BOTTINI M.
J Nanosci Nanotechnol. 8(5):2259-69, 2008. IF 1.987
COMPARATIVE GENOTOXICITY OF COBALT NANOPARTICLES AND IONS ON HUMAN PERIPHERAL LEUKOCYTES IN VITRO. COLOGNATO R, BONELLI A, PONTI J, FARINA M, BERGAMASCHI E, SABBIONI E, MIGLIORE L.
Mutagenesis. VOL. 23; 377-382, 2008. IF 3.541
OCCUPATIONAL EXPOSURE TO NANOMATERIALS: PRESENT KNOWLEDGE AND FUTURE DEVELOPMENT. BERGAMASCHI E.
Nanotoxicology, 3(3); 194-201, 2009. IF 5.774
A TOXICOLOGICAL APPROACH TO HAZARD ASSESSMENT OF CARBON NANOTUBES: IMPLICATIONS FOR WORKERS’ HEALTH PROTECTION. BERGAMASCHI E, IAVICOLI I, BUSSOLATI O, PIETROIUSTI A, MAGRINI A, BERGAMASCHI A.
Int J Environ Health, Inderscience Publishers, Vol. 3 (3), 249-263, 2009.
AIRWAY BARRIER DYSFUNCTION INDUCED BY EXPOSURE TO CARBON NANOTUBES IN VITRO: WHICH ROLE FOR FIBRE LENGTH? BM ROTOLI, O BUSSOLATI, A BARILLI, PP ZANELLO, MG BIANCHI, A MAGRINI, A PIETROIUSTI, A BERGAMASCHI, E BERGAMASCHI.
Human & Experimental Toxicology, Vol 28: 361–368, 2009. IF 1.456
CARDIAC AUTONOMIC REGULATION AFTER LUNG EXPOSURE TO CARBON NANOTUBES. J M LEGRAMANTE, F VALENTINI, A MAGRINI, G PALLESCHI, S SACCO, I IAVICOLI, M PALLANTE, D MOSCONE, A GALANTE, E BERGAMASCHI, A BERGAMASCHI, A PIETROIUSTI.
Human & Experimental Toxicology, Vol 28: 369–375, 2009. IF 1.456
CARBON NANOTUBES INDUCE OXIDATIVE DNA DAMAGE IN RAW 264.7 CELLS. MIGLIORE L., SARACINO D., BONELLI A., COLOGNATO R., D’ERRICO M.R., MAGRINI A., BERGAMASCHI A, BERGAMASCHI E.
Environmental and Molecular Mutagenesis, Vol 51: 294-303, 2010 IF 2.868
